Supplementary Table 2.
Comparison of clinical outcomes between the HT with AKI and non-HT with RRT groups.
| Variables | HT with AKI | Non-HT with RRT (n=8) | P value | |
|---|---|---|---|---|
| Non-RRT (n=5) | RRT (n=10) | |||
| ECMO during hospitalization, n (%) | 4 (80.0) | 9 (90.0) | 8 (100.0) | 0.218 |
| Duration of ECMO (days), median (IQR) | 8.5 (1.0, 24.3) | 8.0 (5.0, 17.0) | 2.0 (1.3, 5.8) | 0.305 |
| Interval from AKI to RRT start (days), mean±SD | NA | 1.3±1.3 | 0.6±0.7 | 0.994 |
| Duration of RRT (days), median (IQR) | NA | 19.0 (5.0, 27.0) | 23.5 (6.8, 57.5) | 0.819 |
| Type of RRT, n (%) | 1.000 | |||
| CRRT | NA | 9 (90.0) | 8 (100.0) | |
| Intermittent HD | NA | 1 (10.0) | 0 | |
| Recovery from AKI, n (%) | 5 (100.0) | 7 (70.0) | 5 (62.5) | 0.164 |
| Full recovery | 4 (80.0) | 4 (40.0) | 0 | 0.048* |
| Partial recovery | 1 (20.0) | 3 (30.0) | 5 (62.5) | |
| Interval from AKI to renal function recovery (days), median (IQR) | 6.0 (3.5, 15.5) | 22.0 (20.0, 64.0) | 61.0 (37.0, 200.5) | 0.016* |
HT – heart transplantation; AKI – acute kidney injury; RRT – renal replacement therapy; ECMO – extracorporeal membrane oxygenation; IQR – interquartile range; SD – standard deviation; CRRT – continuous renal replacement therapy; HD – kemodialysis.
*
p<0.05, HT-AKI without RRT group versus non-HT with RRT group.